A historic shift in our drug policy has occurred, as the government permit the availability of psilocybin mushrooms for therapeutic purposes. Previously, these substances were heavily restricted, but a mounting body of evidence suggests they potentially offer relief for mental health illnesses like depression. This change represents a key step towa